Search Results - "Selkoe, Dennis J."
-
1
Treatments for Alzheimer's disease emerge
Published in Science (American Association for the Advancement of Science) (06-08-2021)“…Anti-amyloid immunotherapies will provide the first disease-modifying therapeutics Few of life's experiences evoke greater apprehension than a diagnosis of…”
Get full text
Journal Article -
2
The amyloid hypothesis of Alzheimer's disease at 25 years
Published in EMBO molecular medicine (01-06-2016)“…Despite continuing debate about the amyloid β‐protein (or Aβ hypothesis, new lines of evidence from laboratories and clinics worldwide support the concept that…”
Get full text
Journal Article -
3
Preventing Alzheimer's Disease
Published in Science (American Association for the Advancement of Science) (21-09-2012)“…Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not…”
Get full text
Journal Article -
4
Early network dysfunction in Alzheimer's disease
Published in Science (American Association for the Advancement of Science) (09-08-2019)“…Small aggregates of β-amyloid peptide can hyperactivate neurons, which compromises neural networks Aggregation of the β-amyloid peptide (Aβ) in brain regions…”
Get full text
Journal Article -
5
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
Published in Nature reviews. Neuroscience (01-04-2016)“…There has been a surge in the number of papers discussing the idea that inter-neuronal spread of 'pathogenic' proteins contributes to neurodegenerative disease…”
Get full text
Journal Article -
6
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Published in Science (American Association for the Advancement of Science) (06-05-2016)“…Synapse loss in Alzheimer's disease (AD) correlates with cognitive decline. Involvement of microglia and complement in AD has been attributed to…”
Get full text
Journal Article -
7
The therapeutics of Alzheimer's disease: Where we stand and where we are heading
Published in Annals of neurology (01-09-2013)“…Few diagnoses in modern medicine evoke more apprehension in patients and their families than Alzheimer disease (AD). Defined as a clinical and pathological…”
Get full text
Journal Article -
8
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Published in Proceedings of the National Academy of Sciences - PNAS (05-04-2011)“…Alzheimer disease is a major cause of cognitive failure, and a pathogenically related but more subtle process accounts for many cases of mild memory symptoms…”
Get full text
Journal Article -
9
Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
Published in Nature cell biology (01-11-2004)“…The salutary intersection of fundamental cell biology with the study of disease is well illustrated by the emerging elucidation of neurodegenerative disorders…”
Get full text
Journal Article -
10
Alzheimer's Disease Is a Synaptic Failure
Published in Science (American Association for the Advancement of Science) (25-10-2002)“…In its earliest clinical phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory. Mounting evidence suggests that this…”
Get full text
Journal Article -
11
SnapShot: Pathobiology of Alzheimer's Disease
Published in Cell (18-07-2013)Get full text
Journal Article -
12
Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers
Published in Neuron (Cambridge, Mass.) (06-03-2013)“…A central question about human brain aging is whether cognitive enrichment slows the development of Alzheimer changes. Here, we show that prolonged exposure to…”
Get full text
Journal Article -
13
Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
Published in Neuron (Cambridge, Mass.) (16-04-2014)“…Soluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer’s disease, but their dynamics in vivo remain unclear. Here, we found that soluble…”
Get full text
Journal Article -
14
Nicastrin functions to sterically hinder γ-secretase–substrate interactions driven by substrate transmembrane domain
Published in Proceedings of the National Academy of Sciences - PNAS (02-02-2016)“…γ-Secretase is an intramembrane-cleaving protease that processes many type-I integral membrane proteins within the lipid bilayer, an event preceded by shedding…”
Get full text
Journal Article -
15
The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking
Published in Journal of neurochemistry (01-06-2011)“…J. Neurochem. (2011) 117, 856–867. Intramembrane proteolysis is a conserved mechanism that regulates a variety of cellular processes ranging from transcription…”
Get full text
Journal Article -
16
miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients
Published in Frontiers in neuroscience (26-11-2019)“…It was recently discovered that brain cells release extracellular vesicles (EV) which can pass from brain into blood. These findings raise the possibility that…”
Get full text
Journal Article -
17
The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons
Published in Human molecular genetics (01-07-2014)“…Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by extracellular plaques containing amyloid β (Aβ)-protein and intracellular…”
Get full text
Journal Article -
18
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
Published in Science (American Association for the Advancement of Science) (19-07-2002)“…It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid…”
Get full text
Journal Article -
19
Alzheimer's Disease: Genes, Proteins, and Therapy
Published in Physiological reviews (01-04-2001)“…Department of Neurology and Program in Neuroscience, Harvard Medical School, and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston,…”
Get full text
Journal Article -
20
N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation
Published in PloS one (30-07-2014)“…A switch in the conformational properties of α-synuclein (αS) is hypothesized to be a key step in the pathogenic mechanism of Parkinson's disease (PD). Whereas…”
Get full text
Journal Article